Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals
Jessica N. Peel(University of Alabama at Birmingham), Jean‐Laurent Casanova(Howard Hughes Medical Institute), Emmanuel Lafont(Hôpital Européen), Paul Bastard(Inserm), Wei‐Te Lei(Chang Gung University), Jing-Ya Ding(Chang Gung University), Camille Soudée(Inserm), Aaron Bodansky(University of California, San Francisco), Danyel Lee(Inserm), Adrian Gervais(Inserm), Pierre Tiberghien(Inserm), Roxana Genet(Centre Hospitalier Régional de Metz-Thionville), Ahmad Yatim(University of Lausanne), Nils Landegren(Science for Life Laboratory), Fernando Messina(Hospital Muñiz), Souad Mehlal-Sedkaoui(Saint-Gobain (France)), Fernando Martin, L. Karkowski(Hôpital d'Instruction des Armées Sainte-Anne), Anish Behere(Uppsala University), Laurie Toullec(Hôpital Cochin), Lucy Bizien(Inserm), Jérémie Rosain(Inserm), Mélanie Migaud(Inserm), Laura Pérez(Garrahan Hospital), Tom Le Voyer(Inserm), Anne Puel(Inserm), Emmanuelle Jouanguy(Inserm), Jonathan Bohlen(Inserm), Axel Cederholm(Uppsala University), Yoann Seeleuthner(Inserm), Jacinta Bustamante(Inserm), Claire Goulvestre(Délégation Paris 5), Masato Ogishi(Rockefeller University), Stéphanie Boisson‐Dupuis(Inserm), Clément Conil(Inserm), Cheng‐Lung Ku(Délégation Paris 5), Laurent Abel(Inserm), Mark S. Anderson(University of California, San Francisco), Rui Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jérôme Sallette, Thomas Perpoint(Hospices Civils de Lyon), Mathieu Blot
Cited by 15
Related Papers
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k